Cite
How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh).
MLA
Chakrabarti, Prantar, et al. “How Do Patients and Physicians Perceive Immune Thrombocytopenia (ITP) as a Disease? Results from Indian Analysis of ITP World Impact Survey (I-WISh).” Journal of Patient-Reported Outcomes, vol. 6, no. 1, Mar. 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s41687-022-00429-y.
APA
Chakrabarti, P., George, B., Shanmukhaiah, C., Sharma, L. M., Udupi, S., & Ghanima, W. (2022). How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh). Journal of Patient-Reported Outcomes, 6(1), 1–14. https://doi.org/10.1186/s41687-022-00429-y
Chicago
Chakrabarti, Prantar, Biju George, Chandrakala Shanmukhaiah, Lalit Mohan Sharma, Shashank Udupi, and Waleed Ghanima. 2022. “How Do Patients and Physicians Perceive Immune Thrombocytopenia (ITP) as a Disease? Results from Indian Analysis of ITP World Impact Survey (I-WISh).” Journal of Patient-Reported Outcomes 6 (1): 1–14. doi:10.1186/s41687-022-00429-y.